Abstract
Ten of 12 strains of Mycobacteria (11 M. tuberculosis, 1 M. bovis) including 7 resistant strains were found to be sensitive to tetradecyl-dimethyl-benzyl-ammonium fluoride (TDBAF) at a concentration of 15–7.75 µg/ml (end point 10 µg/ml). A single multi-resistant strain of M. tuberculosis and a culture of M. bovis were also sensitive but at a slightly higher level.
Similar content being viewed by others
References
Domagk, G. Eine neue Klasse von Desinfektionsmitteln. Deut. med. Wochsohr. 1935; 61: 829.
Buisson, C. Thesis for Doctor of Pharmacy René Descartes University. 1996.
Puts, J. P. Tolerance of tetradecyl-dimethyl-benzyl-ammonium fluoride in severe infections: Interest of administration through central venous catheter. Communication à la 9ème Conférence sur le SIDA en Afrique: Kampala, Uganda. 1995.
Mpoudi NGOlle, E., Siboulet, A. Une Nouvelle thérapeutique combinée du SIDA. Communication aux Premières Journées Internationales de Médecine des Forces Armées et de Police, Yaoundé, République du Cameroun. 1995.
Marty, B., Connaulte, D. Report to Aromapharm Ireland Ltd. 1994.
Bleau, G. Pharmacokinetic study of F-84 in mice: Distribution of radioactivity after the injection of tritiated FTDBA. Report to Aromapharm Ireland Ltd. 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Byrne, C., Healy, T.M. Efficacy of a new quarternary ammonium compound against TB. Ir. J. Med. Sc. 168, 45–46 (1999). https://doi.org/10.1007/BF02939581
Issue Date:
DOI: https://doi.org/10.1007/BF02939581